Insider · CIK 0001906986
Krista Fogarty
Files at LPCN (Lipocine Inc.). First filing -, latest -.
Krista Fogarty files SEC Form 4 as officer at LPCN (Lipocine Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Krista Fogarty has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 2 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 18, 2025 | LPCN Lipocine Inc. | AGrant or award Stock Option (Right to Buy)derivative | +20,786 | $4.20 | $87k | 40,146 | Dec 19, 2025 |
| Dec 23, 2024 | LPCN Lipocine Inc. | AGrant or award Stock Option (Right to Buy)derivative | +5,943 | $4.80 | $29k | 19,460 | Dec 30, 2024 |
Questions about Krista Fogarty
Answered from the filings on this page, as of the latest one.
Is Krista Fogarty buying or selling?
Krista Fogarty has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Krista Fogarty's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Krista Fogarty has 0.
Where does Krista Fogarty file Form 4?
Krista Fogarty has filed Form 4 at LPCN (Lipocine Inc.) as Principal Accounting Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.